Correlation Between HCW Biologics and Rani Therapeutics
Can any of the company-specific risk be diversified away by investing in both HCW Biologics and Rani Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and Rani Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HCW Biologics and Rani Therapeutics Holdings, you can compare the effects of market volatilities on HCW Biologics and Rani Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of Rani Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and Rani Therapeutics.
Diversification Opportunities for HCW Biologics and Rani Therapeutics
-0.31 | Correlation Coefficient |
Very good diversification
The 3 months correlation between HCW and Rani is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and Rani Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rani Therapeutics and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with Rani Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rani Therapeutics has no effect on the direction of HCW Biologics i.e., HCW Biologics and Rani Therapeutics go up and down completely randomly.
Pair Corralation between HCW Biologics and Rani Therapeutics
Given the investment horizon of 90 days HCW Biologics is expected to generate 2.79 times more return on investment than Rani Therapeutics. However, HCW Biologics is 2.79 times more volatile than Rani Therapeutics Holdings. It trades about 0.02 of its potential returns per unit of risk. Rani Therapeutics Holdings is currently generating about 0.0 per unit of risk. If you would invest 211.00 in HCW Biologics on September 2, 2024 and sell it today you would lose (164.00) from holding HCW Biologics or give up 77.73% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
HCW Biologics vs. Rani Therapeutics Holdings
Performance |
| Timeline |
| HCW Biologics |
| Rani Therapeutics |
HCW Biologics and Rani Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with HCW Biologics and Rani Therapeutics
The main advantage of trading using opposite HCW Biologics and Rani Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, Rani Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rani Therapeutics will offset losses from the drop in Rani Therapeutics' long position.| HCW Biologics vs. Anebulo Pharmaceuticals | HCW Biologics vs. Rezolute | HCW Biologics vs. Eliem Therapeutics | HCW Biologics vs. Molecular Partners AG |
| Rani Therapeutics vs. Vincerx Pharma | Rani Therapeutics vs. Tenaya Therapeutics | Rani Therapeutics vs. Corvus Pharmaceuticals | Rani Therapeutics vs. Alx Oncology Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |